Atlas Trials

The Value of Post-radiation Detectable Plasma EBV DNA in High-risk Nasopharyngeal Carcinoma Patients

Clinical trial NCT03981224 · COMPLETED

Trial details

NCT number
NCT03981224
Sponsor
Taichung Veterans General Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Nasopharyngeal Carcinoma
Start date
2012-05-02
Primary completion
2013-05-01
Enrollment
706

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.